In acute myeloid leukemia (AML), abnormal expression of PTK2 is associated with poor prognosis and treatment resistance (18); therefore, exploring the role of PTK2 in APL is of great significance for understanding the relationship between lipid metabolism disorders and APL. This evidence concerns the gene PTK2 and acute myeloid leukemia.